ribavirin has been researched along with Autoimmune Diabetes in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (50.00) | 29.6817 |
| 2010's | 9 (37.50) | 24.3611 |
| 2020's | 3 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Jasonek, J; Kacprzak-Bergman, I; Zaleska, I | 1 |
| Barker, P; Dahl-Jørgensen, K; Hanssen, KF; Hessel, TW; Hyöty, H; Johannesen, J; Krogvold, L; Lindblom, N; Ludvigsson, J; Mynarek, IM; Mørk, FB; Ponzi, E; Roald, T; Westman, J | 1 |
| Honkimaa, A; Hyöty, H; Sioofy-Khojine, AB | 1 |
| Berggren, PO; Juntti-Berggren, L; Klitz, W; Lindquist, L; Niklasson, B | 1 |
| Attarian, S; Haigentz, M; Kaubisch, A; Sharma, J; Zonszein, J | 1 |
| Arama, V; Popescu, C; Popescu, GA | 1 |
| Alraies, MC; Alraiyes, AH; Alsabbagh, ME; Eisa, N | 1 |
| Blanchard, E; Samaras, K; Vickers, CR | 1 |
| Hinokio, Y; Imai, J; Ishigaki, Y; Katagiri, H; Kudo, H; Ogihara, T; Oka, Y; Shimosegawa, T; Ueno, Y; Yamada, T; Yamagiwa, Y | 1 |
| Hayashi, M; Kataoka, Y; Koguchi, H; Tachikawa, K; Tanaka, H | 1 |
| Berggren, PO; Blixt, M; Holmberg, R; Juntti-Berggren, L; Klitz, W; Niklasson, B | 1 |
| Corcoy, R; Enríquez, J; Rigla, M; Torras, X; Vinagre, I | 1 |
| Fujioka, T; Honda, M; Koyama, K; Matsuno, H; Ogawa, M; Shimokawa, K; Yoshizaki, T | 1 |
| Awata, T; Hanafusa, T; Ikegami, H; Imagawa, A; Kawasaki, E; Kobayashi, T; Makino, H; Maruyama, T; Nakamura, K; Nakanishi, K; Shimada, A; Uchigata, Y | 1 |
| Ishibashi, S; Nagasaka, S; Okada, K; Okada, N; Osuga, J; Sato, S; Sugano, K; Yagyu, H; Yamashita, Y | 1 |
| Araki, M; Kawazoe, T; Lin, Y; Murata, M; Ogawa, M; Okamoto, T; Wakakura, M; Yamamura, T | 1 |
| Primo Vera, J | 1 |
| Christensen, UB; Krogsgaard, K | 1 |
| Peters, T; Rasenack, J; Reincke, M; Schories, M | 1 |
| Betterle, C; Cozzolongo, R; Fabris, P; Lanzilotta, E; Manghisi, OG; Paola Albergoni, M | 1 |
| Devries, JH; Gelderblom, HC; Hamann, D; Hoekstra, JB; Jansen, PL; Reesink, HW; Schreuder, TC; Weegink, CJ | 1 |
| Beppu, T; Fuke, H; Ito, K; Shiraki, K; Sugimoto, K; Takei, Y; Tanaka, J; Yamamoto, N; Yoneda, K | 1 |
| Bhatti, A; Gabbay, R; McGarrity, TJ | 1 |
| Eibl, MM; Eibl, N; Ferenci, P; Gschwantler, M; Schernthaner, G; Weiss, W | 1 |
1 review(s) available for ribavirin and Autoimmune Diabetes
| Article | Year |
|---|---|
New-onset type 1 diabetes mellitus and anti-aquaporin-4 antibody positive optic neuritis associated with type 1 interferon therapy for chronic hepatitis C.
Topics: Antibodies, Anti-Idiotypic; Antiviral Agents; Aquaporin 4; Diabetes Mellitus, Type 1; Drug Synergism; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon Type I; Interferon-alpha; Interferon-beta; Middle Aged; Optic Neuritis; Ribavirin | 2012 |
2 trial(s) available for ribavirin and Autoimmune Diabetes
| Article | Year |
|---|---|
Pleconaril and ribavirin in new-onset type 1 diabetes: a phase 2 randomized trial.
Topics: Adolescent; Antiviral Agents; C-Peptide; Child; Diabetes Mellitus, Type 1; Double-Blind Method; Humans; Ribavirin | 2023 |
[Autoantibodies against islet cell antigens and type 1 diabetes after treatment with interferon-alpha].
Topics: Amantadine; Antiviral Agents; Autoantibodies; Diabetes Mellitus, Type 1; Double-Blind Method; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Islets of Langerhans; Male; Middle Aged; Randomized Controlled Trials as Topic; Retrospective Studies; Ribavirin; Treatment Failure | 2004 |
21 other study(ies) available for ribavirin and Autoimmune Diabetes
| Article | Year |
|---|---|
[The treatment of HCV infection with interferon alpha and ribavirin in a child with diabetes I type].
Topics: Adolescent; Antiviral Agents; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Ribavirin; Treatment Outcome | 2006 |
A preclinical assessment to repurpose drugs to target type 1 diabetes-associated type B coxsackieviruses.
Topics: A549 Cells; Amides; Antiviral Agents; Azithromycin; Benzimidazoles; Coxsackievirus Infections; Diabetes Mellitus, Type 1; Drug Repositioning; Enterovirus B, Human; Fluoxetine; Guanidine; Humans; Immunoglobulin G; Lovastatin; Oxadiazoles; Oxazoles; Oximes; Pyrazines; Ribavirin; Sulfonamides | 2020 |
Effectiveness of Antivirals in a Type 1 Diabetes Model and the Move Toward Human Trials.
Topics: Adult; Alkynes; Animals; Antiviral Agents; Benzoxazines; Cyclopropanes; Diabetes Mellitus, Type 1; Humans; Male; Oxadiazoles; Oxazoles; Proof of Concept Study; Rats; Ribavirin | 2020 |
Multiple Endocrine and Neoplastic Diseases After Unsuccessful Treatment of Hepatitis C With Interferon and Ribavirin.
Topics: Carcinoma, Hepatocellular; Diabetes Mellitus, Type 1; Humans; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Polyendocrinopathies, Autoimmune; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thyroid Diseases | 2017 |
Type 1 diabetes mellitus with dual autoimmune mechanism related to pegylated interferon and ribavirin treatment for chronic HCV hepatitis.
Topics: Antiviral Agents; Autoantibodies; Autoimmune Diseases; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Hashimoto Disease; Hepatitis C, Chronic; Humans; Insulin Resistance; Interferon-alpha; Islets of Langerhans; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Vitiligo; Young Adult | 2013 |
Chronic hepatitis C therapy: a rare complication revisited.
Topics: Administration, Cutaneous; Antiviral Agents; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Oligopeptides; Recombinant Proteins; Ribavirin | 2013 |
Not so sweet: autoimmune diabetes mellitus on triple therapy for chronic hepatitis C infection.
Topics: Adult; Antiviral Agents; Autoimmune Diseases; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Genetic Predisposition to Disease; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferons; Interleukins; Oligopeptides; Polyethylene Glycols; Polymorphism, Single Nucleotide; Proline; Protease Inhibitors; Ribavirin; Young Adult | 2015 |
Peginterferon (PEG-IFN) plus ribavirin combination therapy, but neither interferon nor PGE-IFN alone, induced type 1 diabetes in a patient with chronic hepatitis C.
Topics: Blood Glucose; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2009 |
Dual onset of type 1 diabetes mellitus and Graves' disease during treatment with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
Topics: Antiviral Agents; Autoimmune Diseases; Diabetes Mellitus, Type 1; Female; Graves Disease; Hepatitis C, Chronic; Histocompatibility Antigens Class I; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2009 |
Antiviral treatments reduce severity of diabetes in Ljungan virus-infected CD-1 mice and delay onset in diabetes-prone BB rats.
Topics: Animals; Antibodies, Viral; Antiviral Agents; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Humans; Immunologic Factors; Mice; Oxadiazoles; Oxazoles; Parechovirus; Picornaviridae Infections; Rats; Rats, Inbred BB; Ribavirin | 2009 |
[Type 1 diabetes developing during alpha-interferon therapy: report of two cases].
Topics: Adult; Antiviral Agents; Autoantibodies; Autoimmune Diseases; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Glutamate Decarboxylase; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2010 |
A case of type 1 diabetes onset and recurrence of Graves' disease during pegylated interferon-α plus ribavirin treatment for chronic hepatitis C.
Topics: Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Graves Disease; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyendocrinopathies, Autoimmune; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Secondary Prevention; Treatment Outcome | 2010 |
Type 1 diabetes and interferon therapy: a nationwide survey in Japan.
Topics: Antiviral Agents; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Female; HLA-DR Serological Subtypes; HLA-DR4 Antigen; Humans; Interferons; Japan; Male; Middle Aged; Ribavirin | 2011 |
Pegylated interferon-α2b and ribavirin combination therapy induces Hashitoxicosis followed by type 1 diabetes mellitus.
Topics: Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Hashimoto Disease; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thyrotoxicosis | 2012 |
[Pegylated-interferon-induced diabetes mellitus type 1 in two patients with chronic hepatitis C].
Topics: Adult; Antiviral Agents; Autoantibodies; Autoantigens; Autoimmune Diseases; Diabetes Mellitus, Type 1; Glutamate Decarboxylase; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Islets of Langerhans; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2004 |
[Onset of type 1 diabetes mellitus during combination therapy of chronic hepatitis C with interferon-alpha and ribavirin].
Topics: Antiviral Agents; Autoimmunity; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Ribavirin | 2004 |
Onset of type 1 diabetes mellitus during peginterferon alpha-2b plus ribavirin treatment for chronic hepatitis C.
Topics: Antiviral Agents; Autoimmunity; Chronic Disease; Combined Modality Therapy; Diabetes Mellitus, Type 1; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2006 |
High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon alpha for chronic hepatitis C virus infection.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; DNA Probes, HLA; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2008 |
Type 1 diabetes mellitus provoked by peginterferon alpha-2b plus ribavirin treatment for chronic hepatitis C.
Topics: Antiviral Agents; Blood Glucose; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Glutamate Decarboxylase; Hepatitis C, Chronic; Humans; Hypoglycemic Agents; Insulin; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2008 |
Diabetic ketoacidosis induced by alpha interferon and ribavirin treatment in a patient with hepatitis C.
Topics: Antiviral Agents; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Recombinant Proteins; Ribavirin | 2001 |
Development of insulin-dependent diabetes mellitus in a patient with chronic hepatitis C during therapy with interferon-alpha.
Topics: Adult; Antibodies; Antiviral Agents; Autoimmunity; Diabetes Mellitus, Type 1; Glutamate Decarboxylase; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Recombinant Proteins; Ribavirin; Risk | 2001 |